StockData
Eikon Therapeutics, Inc. logo

Eikon Therapeutics, Inc. (EIKN) stock

EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.15−0.23 (-4.36%)

Close on Nov 17, 2026Market cap $278.95MP/E –Yield –

Eikon Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.63–
Q1 FY2026Mar 31, 2026-$2.46–
Q2 FY2025Jun 30, 2025-$36.94–
Q1 FY2025Mar 31, 2025-$26.91–

More Eikon Therapeutics figures

See a number that looks wrong?